Subcutaneous immunology biologics face structural formulary and prescriber inertia barriers that require active managed care contracting and patient support investment to overcome
doi: 10.7326/AITC202007070 63 MeiL.WangJ.HaoY.ZengX.YangY.WuZ.et al
Alba objects to a proposed use of the licensed property, we may be prevented from implementing our business plan in a timely manner, or at all, outside of previously approved usages or usages consistent with certain pre-approved product guidelines. 2
Several domestic pharmaceutical companies are now bracing for a 25-30% downward revision in sales targets, according to reports, amid sluggish prescription growth, mounting inventory and a problem nobody had quite anticipated, that patients are quitting
Hepatic-portal vein infusions of glucagon-like peptide-1 reduce meal size and increase c-Fos expression in the nucleus tractus solitarii, area postrema and central nucleus of the amygdala in rats
Requirement of the phosphatidylinositol 3-kinase/Akt signaling pathway for the effect of nicotine on interleukin-1beta-induced chondrocyte apoptosis in a rat model of osteoarthritis
